In this review:
Ibrutinib warrants further study in CLL
ABT-199: promising in refractory CLL
Less toxic BEACOPP in advanced-stage HL
A single IV iron dose benefits iron-deficient, non-anaemic women
Cardiac MRI in the management of â-thalassemia major
Blinatumomab promising
Please login below to download this issue (PDF)